Authors
Latest:
Managing the complexities of glaucoma care with Ying Han, MD, PhDYing Han, MD, PhD discusses glaucoma management strategies, including transitioning care between ophthalmologists and optometrists, improving diagnosis, and the hope for future glaucoma developments.
Latest:
Strategies for coping with physician depression during COVID-19Medical practitioners face emotional burden, other hurdles from pandemic
Latest:
ARVO 2025: Shortened, maintained, or extended dosing intervals through 96 weeks in PHOTONAt ARVO 2025, in Salt Lake City, Utah, Dilsher Dhoot, MD, FASRS, and Mark Barakat, MD, talked about the PHOTON trial, 8 mg versus 2 mg during the matched dosing phase, and outcomes of shortened, maintained, or extended dosing intervals
Latest:
Partners collaborate on integration of AI-supported ROP telemedicine globallySiloam Vision and Orbis team up to develop infrastructure to save the vision of premature infants.
Latest:
The importance of ocular health prior to cataract and refractive surgeryDr. Jai Parekh, a clinical associate professor of Ophthalmology/The New York Eye & Infirmary of the Mount Sinai School of Medicine and David Hutton, Managing Editor of Opthalmology Times discuss the importance of ocular health prior to cataract and refractive surgery, specifically with osmolarity testing.
Latest:
World Sight Day 2023: Understanding and alleviating digital eye fatigueStephanie Marioneaux, MD, an ophthalmologist and cornea specialist, addresses the widespread issue of digital eye strain in honor of World Sight Day.
Latest:
Study: Accurate refractive predictions remain difficult in patients with keratoconusNewer generation formulas generally outperformed older generation formulas, with SRK/T performing the best of older formulas, especially when using TK values.
Latest:
(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuckFrom revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption
Latest:
Ravi Patel, MD, shares ASCRS 2025 insights on enVista ASPIRE IOL user experienceDiscover how real-world evidence shapes cataract surgery practices, highlighting user satisfaction with enhanced monofocal IOLs at the 2025 ASCRS Annual Meeting.
Latest:
Harnessing the Power of VR for Visual Field Testing: Results of The NOVA TrialLorraine Provencher, MD, reviews the NOVA trial which measured and validated the sensitivity of a novel VR-based wearable headset for visual field testing in glaucoma.
Latest:
Optimizing ocular surface to achieve full visual potential continues after surgeryAlthough it is always important to consider optimizing the ocular surface for all patients to improve their vision, it is of critical importance before cataract surgery.
Latest:
Final Thoughts on Case Presentations and Advanced TherapiesRetinal specialists conclude their discussion with key highlights from each patient case of retinal vascular disease and pearls the audience can apply in their practice.
Latest:
AGS 2025: Long-term efficacy and safety of standalone and phaco ELT with Marc Toeteberg-Harms, MDA systematic review and meta-analysis highlights the safety and efficacy of excimer laser trabeculostomy as an implant-free MIGS procedure for managing open-angle glaucoma and ocular hypertension, either alone or in combination with cataract surgery.
Latest:
AGS 2025: Aqueous humor outflow improvement after excimer laser trabeculostomy with Clemens Strohmaier, PhDThe Elios procedure increased aqueous humor outflow in all investigated eyes, but further studies are needed to correlate these improvements with its clinical efficacy.
Latest:
MIGS helping to personalize glaucoma surgery optionsAlthough minimally invasive procedure gives hope, additional research is required.
Latest:
Shine on social media like ModaMD: Real World OphthalmologyAn overview of Jesse Berry’s advice for starting and growing a social media account
Latest:
Ophthalmologists present data on perfluorohexyloctane eye dropsResearchers share that perfluorohexyloctane eye drops offer rapid relief for dry eye disease, enhancing patient comfort before cataract surgery.
Latest:
Boosting short-term dry eye management in patientsFast-acting efficacious options are key to treating acute inflammation
Latest:
ARVO 2025: Post-hoc analysis on GATHER 2 clinical trial dataGiullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for geographic atrophy and age-related macular degeneration.
Latest:
IKA Keratoconus Symposium 2023: Strategies for early diagnosisAt the IKA Keratoconus Symposium, Justin Schweitzer, OD, FAAO, presented on establishing the keratoconus diagnosis alongside Kourtney Houser, MD.
Latest:
ASCRS 2025: Rotational stability and outcomes with 'monofocal plus' toric IOL with Gregory Moloney, FRANZCO, FRCSCA study reports minimal rotation and improved near vision following implantation of the Eyhance toric lens.
Latest:
Keratoconus and perfect vision: Is it possible?Eye care providers must look beyond visual acuity in screening for disease.
Latest:
Children’s mental health and the impact of vision impairmentTwo studies conducted in collaboration with Orbis International explore how providing free glasses to children improves their ability to learn in school and that addressing visual impairment in children can alleviate depression and anxiety.
Latest:
Q&A: David S. Boyer, MD, on the suprachordial delivery of gene therapyBoyer discusses a potential treatment for diabetic retinopathy and macular degeneration using suprachoroidal injections, offering reduced risks and improved outcomes.
Latest:
IKA Keratoconus Symposium 2023: In-person white paper development, live patient Q&APresident and CEO of the International Keratoconus Academy Andrew Morgenstern, OD, FAAO, FNAP, shares some snippets about the live white paper development session and the patient Q&A happening at the inaugural IKA Keratoconus Symposium.
Latest:
Connecting the dots between the complement pathway and geographic atrophyCurrently enrolling a Phase 2 trial to evaluate the role of complement factor B protein in age-related macular degeneration (AMD)
Latest:
The tech savvy physician: How AI will transform your practiceInvestigators find technology aids instruction of medical students
Latest:
(Part 2) From ophthalmology’s lockdown to lasting change: The pandemic habits that stuckFrom revised patient flow to smarter tech adoption, ophthalmologists share which changes from 2020 have become cornerstones of modern care—and how they’re preparing for the next big disruption
